bd 1047 has been researched along with venlafaxine hydrochloride in 1 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (venlafaxine hydrochloride) | Trials (venlafaxine hydrochloride) | Recent Studies (post-2010) (venlafaxine hydrochloride) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 2,846 | 686 | 1,136 |
| Protein | Taxonomy | bd 1047 (IC50) | venlafaxine hydrochloride (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.9466 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.18 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhir, A; Kulkarni, SK | 1 |
1 other study(ies) available for bd 1047 and venlafaxine hydrochloride
| Article | Year |
|---|---|
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Carbazoles; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Receptors, sigma; Sigma-1 Receptor; Swimming; Venlafaxine Hydrochloride | 2007 |